Table 2. Results and follow-up.

Technical success, n. (%)	21 (100)
Clinical success, n. (%)	21 (100)
LAMS size (diameter × length)
6 mm × 8 mm, n. (%)	1 (4.76)
8 mm × 8 mm, n. (%)	16 (76.1)
10 mm × 10 mm, n. (%)	3 (14.28)
15 mm × 10 mm, n. (%)	1 (4.76)
Pretreatment bilirubin level, mean	13.9 mg/dl
Bilirubin level after 2 weeks, mean	2.3 mg/dl
Pretreatment CBD size: mean (range), mm	16 (12–20)
Adverse events, n. (%)	1 (4.76)
Reinterventions, n. (%)	1 (4.76)
Jaundice recurrence, n. (%)	3 (17)
Follow-up: mean (range), days	188 (8–554)
Survival time: mean (range), days	161 (8–419)

LAMS, lumen-apposing metal stent.